[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100417877":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":48,"collaborators":50,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Yale University","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Cocaine Use Disorder",null,[12],"Radiation: 11C-UCB-J",{"label":14,"type":10,"description":10,"interventionNames":15},"Healthy Control",[12],[17],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"RADIATION","11C-UCB-J","11C-UCB-J PET scan",[9,14],[23],{"name":24,"affiliation":5,"role":25},"Gustavo Angarita, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Marcella Mignosa, MD","CONTACT","203 974 7557","marcella.mignosa@yale.edu",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Connecticut Mental Health Center","RECRUITING","New Haven","Connecticut","06519","United States",{"type":41,"coordinates":42},"Point",[43,44],-72.92816,41.30815,{"lat":44,"lon":43},[47],{"name":24,"role":29,"phone":10,"phoneExt":10,"email":10},{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[51],{"name":52,"class":53},"National Institute on Drug Abuse (NIDA)","NIH","100417877",false,"NCT04721418","Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study","Inclusion Criteria:\n\n* Age 21-60 years\n* Physically healthy by medical history, physical, neurological, ECG and laboratory examinations\n* For females, a negative serum pregnancy test\n* For CUD: DSM-5 criteria for Cocaine Use Disorder and positive urine toxicology showing recent use\n* For HC: Negative urine toxicology\n\nExclusion Criteria:\n\n* DSM-5 criteria for other substance use disorders (e.g., alcohol, opiates, sedative hypnotics), except for nicotine\n* A primary DSM-5 Axis I major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depression, etc.) as determined by the Structured Clinical Interview for DSM-5 (SCID-5)\n* A history of significant and\u002For uncontrolled medical or neurological illness\n* Current use of psychotropic and\u002For potentially psychoactive prescription medications\n* Medical contraindications to MRI procedure",true,"ALL","21 Years","60 Years",{"count":64,"type":65},80,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.",[9,69],"Healthy Controls","2025-09-09",{"date":72,"type":73},"2025-09-11","ACTUAL",{"date":75,"type":73},"2021-07-20",{"date":77,"type":65},"2026-06",{"name":5,"class":6},1]